Sanofi and GlaxoSmithKline announced in Security Exchange Commission (SEC) filings that the Department of Justice and the U.S. Attorney’s Office for the Eastern District of Pennsylvania have opened an investigation into their reporting of potentially contaminated Zantac (ranitidine).

Type 2 Diabetes drug metformin is the latest medicine to be recalled due to unacceptable levels of the probable human carcinogen NDMA (N-Nitrosodimethylamine).

The FDA said it found unacceptable levels of NDMA (N-Nitrosodimethylamine) in extended-release versions of the type 2 diabetes drug metformin.